Journal of Tuberculosis and Lung Health ›› 2019, Vol. 8 ›› Issue (4): 244-248.doi: 10.3969/j.issn.2095-3755.2019.04.003
• Expert Forum • Previous Articles Next Articles
Received:
2019-10-29
Online:
2019-12-30
Published:
2019-12-30
Contact:
Hui ZHANG
E-mail:zhanghui@chinacdc.cn
Ni WANG,Fei HUANG,Hui ZHANG. Implementation electronic medication monitor in tuberculosis medication management[J]. Journal of Tuberculosis and Lung Health , 2019, 8(4): 244-248. doi: 10.3969/j.issn.2095-3755.2019.04.003
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.3969/j.issn.2095-3755.2019.04.003
[1] |
World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
doi: 10.9745/GHSP-D-19-00210 URL pmid: 31852741 |
[2] | 张立兴, 吴基成, 吕淑美 , 等. 农村不住院肺结核病人全面监督化学疗法研究的初步结果. 中国防痨通讯, 1980,2(1):13. |
[3] | 兆丰增 . 结核病人的治疗与管理--DOTS策略. 中国预防医学杂志, 2001,2(2):86-89. |
[4] | 中华人民共和国卫生部疾病预防与控制司. 中国结核病防治规划实施工作指南. 北京:中华人民共和国卫生部, 2002. |
[5] |
Ogden J, Walt G, Lush L . The politics of ‘branding’ in policy transfer: the case of DOTS for tuberculosis control. Soc Sci Med, 2003,57(1):179-188.
doi: 10.1016/s0277-9536(02)00373-8 URL pmid: 12753826 |
[6] |
World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: World Health Organization, 2017.
doi: 10.1016/j.ccm.2019.07.006 URL pmid: 31731983 |
[7] |
Moulding T . A neglected research approach to prevent acquired drug resistance when treating new tuberculosis patients. Int J Tuberc Lung Dis, 2011,15(7):855-861.
doi: 10.5588/ijtld.10.0486 URL pmid: 21682959 |
[8] |
Hou WL, Song FJ, Zhang NX , et al. Implementation and community involvement in DOTS strategy: a systematic review of studies in China. Int J Tuberc Lung Dis, 2012,16(11):1433-1440.
doi: 10.5588/ijtld.12.0080 URL pmid: 23044444 |
[9] |
Liu X, Lewis JJ, Zhang H , et al. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial. PLoS Med, 2015,12(9):e1001876.
doi: 10.1371/journal.pmed.1001876 URL pmid: 26372470 |
[10] | 王晓梅, 刘剑君, 王娟 , 等. 中国结核病控制直接面视下督导化疗的系统评价. 中华流行病学杂志, 2006,27(1):63-67. |
[11] |
Tesfahuneygn G, Medhin G, Legesse M . Adherence to anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes, 2015,8:503.
doi: 10.1186/s13104-015-1452-x URL pmid: 26420164 |
[12] |
Xu W, Lu W, Zhou Y , et al. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Heal Serv Res, 2009,9:169.
doi: 10.1186/1472-6963-9-169 URL pmid: 19765290 |
[13] |
Kulkarni P, Akarte S, Mankeshwar R , et al. Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment. Ann Med Health Sci Res, 2013,3(1):67-74.
doi: 10.4103/2141-9248.109507 URL pmid: 23634333 |
[14] |
World Health Organization. International Standards for Tuberculosis Care. Geneva: World Health Organization, 2014.
doi: 10.1002/14651858.CD012777.pub2 URL pmid: 31565799 |
[15] | World Health Organization. Handbook for the use of digital technologies to support tuberculoasis medication adherence. Geneva: World Health Organization, 2017. |
[16] | 马艳, 杜建, 刘宇红 , 等. 移动医疗在结核病患者管理中的作用. 中国防痨杂志, 2016,38(7):527-530. |
[17] |
Subbaraman R, de Mondesert L, Musiimenta A , et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Heal, 2018,3(5):e001018.
doi: 10.1136/bmjgh-2018-001018 URL pmid: 30364330 |
[18] | Cross A, Gupta N, Liu B , et al. 99DOTS: A low-cost approach to monitoring and improving medication adherence//Tenth international conference on information and communication technologies and development (ICTD 2019). Ahmedabad(India):Information and Communication Technology for Development Group, 2019. |
[19] |
Vrijens B, Urquhart J, White D . Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin pharmacol, 2014,7(5):633-644.
doi: 10.1586/17512433.2014.940896 URL pmid: 25088004 |
[20] |
Broomhead S, Mars M . Retrospective return on investment analysis of an electronic treatment adherence device piloted in the northern cape province. Telemed J E Health, 2012,18(1):24-31.
doi: 10.1089/tmj.2011.0143 URL pmid: 22150713 |
[21] | 李智, 周惠, 陈晓军 , 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019,41(9):1015-1020. |
[22] |
de Sumari-de Boer IM, van den Boogaard J, Ngowi KM , et al. Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting. AIDS Behav, 2016,20(5):1097-1107.
doi: 10.1007/s10461-015-1254-0 URL pmid: 26604004 |
[23] |
Koss CA, Hosek SG, Bacchetti P , et al. Comparison of Mea-sures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis, 2018,66(2):213-219.
doi: 10.1093/cid/cix755 URL pmid: 29020194 |
[24] | 李雪, 姜世闻, 胡冬梅 , 等. 电子药盒和手机微信APP的应用对肺结核患者服药依从性的效果评价. 中国防痨杂志, 2019,41(9):957-961. |
[25] | 桓世彤, 陈嵘, 刘小秋 , 等. 电子药盒取药记录监测肺结核患者服药行为的可行性评估. 中国防痨杂志, 2012,34(7):419-424. |
[26] |
Liu X, Blaschke T, Thomas B, et al. Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis. Int J Env Res Public Heal, 2017, 14(10). pii: E1115.
doi: 10.3390/ijerph14101115 URL pmid: 28946683 |
[27] |
Wang N, Zhang H, Zhou Y , et al. Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China. BMC Infect Dis, 2019,19(1):844.
doi: 10.1186/s12879-019-4521-2 URL pmid: 31615433 |
[28] |
Wei X, Hicks JP, Pasang P , et al. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet. Trials, 2019,20(1):273.
doi: 10.1186/s13063-019-3364-x URL pmid: 31097023 |
[29] | 刘盛元, 谭卫国, 杨亚蕊 , 等. 重视信息化技术应用促进结核病防治工作. 结核病与肺部健康杂志, 2018,7(1):3-8. |
[30] | 刘小秋 . 我国肺结核患者治疗管理的若干意见. 中国防痨杂志, 2019,41(9):917-919. |
[31] | 姜世闻, 刘小秋 . 《结核病患者健康管理服务规范》要点解读及改进意见和建议. 中国防痨杂志, 2019,41(9):926-929. |
[32] |
Yao S, Huang WH, van den Hof S, et al Treatment adhe-rence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res, 2011,11(3):341.
doi: 10.1186/1472-6963-11-341 URL pmid: 22176718 |
[33] |
Xu M, Markström U, Lyu J , et al. Detection of Low Adhe-rence in Rural Tuberculosis Patients in China: Application of Morisky Medication Adherence Scale. Int J Environ Res Public Health, 2017, 14(3). pii: E248.
doi: 10.3390/ijerph14030248 URL pmid: 28257075 |
[34] |
Lei X, Huang K, Liu Q , et al. Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study. Infect Dis Poverty, 2016,5(1):1-9.
doi: 10.1186/s40249-016-0134-9 URL pmid: 27146470 |
[35] |
Au-Yeung KY, DiCarlo L . Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment. Int J Tuberc Lung Dis, 2012,16(11):1498-1504.
doi: 10.5588/ijtld.11.0868 URL pmid: 23006834 |
[36] |
Checchi KD, Huybrechts KF, Avorn J , et al. Electronic medication packaging devices and medication adherence: a systema-tic review. JAMA, 2014,312(12):1237-1247.
doi: 10.1001/jama.2014.10059 URL pmid: 25247520 |
[37] |
Thakkar D, Piparva KG, Lakkad SG . A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India, 2019,36(2):108-111.
doi: 10.4103/lungindia.lungindia_86_18 URL pmid: 30829243 |
[38] |
Masini EO, Mansour O, Speer CE , et al. Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya. PLoS One, 2016,11(10):e0164172.
doi: 10.1371/journal.pone.0164172 URL pmid: 27706230 |
[39] |
Demonceau J, Ruppar T, Kristanto P , et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs, 2013,73(6):545-562.
doi: 10.1007/s40265-013-0041-3 URL |
[1] | Chang Li, Ren Hong, Guan Xueqing, Pang Youquan, Zhen Chunying, Bian Nannan, Sun Suqin. Correlation between vascular endothelial growth factor (VEGF) expression levels and therapeutic outcomes in patients with malignant pleural effusion [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 533-539. |
[2] | Cai Xiaoting, Wu Xiaoying, He Liqian, Jiang Kunhong. A study on the correlation between family doctor contract services and clinical characteristics of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 333-338. |
[3] | Weng Jianfeng, Chen Wenjie, Liu Zhidong, Chen Hao, Li Xiaofen, Yin Qingqing, Yao Zhuocheng. Analysis of the status and influencing factors of tuberculosis management system based on mobile Wechat [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 457-462. |
[4] | Wang Guowei, Liang Yachong, Liu Yufei, Li Cuiqiao, He Ping. Efficacy observation of Xiaoluo Sanjie Powder combined with conventional anti-tuberculosis drugs in the treatment of infiltrating lymph node tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(1): 60-65. |
[5] | Li Jing, He Jinge, Li Ting, Li Yunkui, Gao Wenfeng. Analysis of feasibility and effectiveness of the implementation of strengthened tuberculosis management model in Liangshan Yi Autonomous Prefecture, Sichuan Province [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 449-454. |
[6] | TIAN Yao, LIU Hui-min, FU Man-jiao, BEI Cheng-li. Diagnosis and treatment of tuberculosis complicated with diabetes [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(2): 91-95. |
[7] | CHEN Zhuang-hao, LIN Jian-xiong, ZENG Li-xiang. Clinical effect of short-term regimen containing levofloxacin in the treatment of newly diagnosed bacteria-positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(1): 19-21. |
[8] | LI Yong, LU Li-ping, LI Jin, ZOU Jin-yan. Analysis of willingness and effect of tuberculosis assistant APP and electronic kit in pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(1): 22-26. |
[9] | AN Hong-xia, YANG Feng-qin, LU Chuan, MA Xiu-xia. Analysis of the effect of extended nursing service by QQ group on health education for tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 265-269. |
[10] | ZHONG Chong-xia, WANG Hua-shan. Analysis on reporting and referral quality of pulmonary tuberculosis cases by general hospitals above level Ⅱ in Shuyang County,Jiangsu Province during 2018—2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 179-182. |
[11] | DENG Guo-fang, LEI Jian-ping. Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19) [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 7-10. |
[12] | WANG Chun-ting, LI Ya-qi, MI Yan, MO Nian-chun, LIU Hong-yan, LE Xing, ZHOU Li, WU Bi-feng, HAN Shi-yun, BAI Li-qiong, ZHANG Chuan-fang. Monitoring of pulmonary function in patients with active tuberculosis during anti-tuberculosis treatment [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 39-44. |
[13] | JING Rui, CAO Yan-min, YANG Yi-jun, WU Hong-yan, CAI Jun-li, REN Wen, ZHANG Wen-qian, WANG Mei-hua. A study of application of electronic pillbox and mobile WeChat APP on pulmonary tuberculosis patient supervision and management of taking medication [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 96-99. |
[14] | Yan MA,Shi-ming CHENG. Current status and challenges of tuberculosis patient management supported by mobile health platform [J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 238-243. |
[15] | Song YANG,Xiao-feng YAN. Current status and future prospects on the treatment of multi/extensively drug-resistant tuberculosis with bedaquiline [J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 249-252. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||